The promise of anti-ErbB3 monoclonals as new cancer therapeutics

Title
The promise of anti-ErbB3 monoclonals as new cancer therapeutics
Authors
Keywords
-
Journal
Oncotarget
Volume 3, Issue 8, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-17
DOI
10.18632/oncotarget.550

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started